skip to Main Content

Dr. Simeone on the Importance of Mutational Analysis in Patients With Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Diane Simeone, M.D., director, Pancreatic Cancer Center, associate director, Translational Research, NYU Langone’s Perlmutter Cancer Center, discusses the importance of mutational analysis in the treatment of patients with pancreatic cancer.

Physicians have typically relied on a patient’s family history when treating pancreatic cancer. However, in many patients with cancer, a complete family history is not taken. Watch the video . . .

Back To Top